Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer
about
RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancerThe Effects and Mechanism of YK-4-279 in Combination with Docetaxel on Prostate Cancer.Anticancer mechanism of apigenin and the implications of GLUT-1 expression in head and neck cancers.A systematic review on phenolic compounds in Passiflora plants: Exploring biodiversity for food, nutrition, and popular medicine.Ocimum sanctum L (Holy Basil or Tulsi) and its phytochemicals in the prevention and treatment of cancer.Ferns and lycopods--a potential treasury of anticancer agents but also a carcinogenic hazard.Flavonoid Fraction of Citrus reticulata Juice Reduces Proliferation and Migration of Anaplastic Thyroid Carcinoma Cells.Biogenesis, characterization, and the effect of vicenin-gold nanoparticles on glucose utilization in 3T3-L1 adipocytes: a bioinformatic approach to illuminate its interaction with PTP 1B and AMPK.Pharmacokinetic properties and drug interactions of apigenin, a natural flavone.Targeting the mercapturic acid pathway and vicenin-2 for prevention of prostate cancer.How Can Synergism of Traditional Medicines Benefit from Network Pharmacology?Understanding the polypharmacological anticancer effects of Xiao Chai Hu Tang via a computational pharmacological model.Identification and functional analysis of 2-hydroxyflavanone C-glucosyltransferase in soybean (Glycine max).Combined blockade of AKT/mTOR pathway inhibits growth of human hemangioma via downregulation of proliferating cell nuclear antigen.Flavonoidal Constituents, Antioxidant, Antimicrobial, and Cytotoxic Activities of Dipterygium glaucum Grown in Kingdom of Saudi Arabia.Chilean prosopis mesocarp flour: phenolic profiling and antioxidant activity.Translational opportunities for broad-spectrum natural phytochemicals and targeted agent combinations in breast cancer.Identification of Major Flavone C-Glycosides and Their Optimized Extraction from Cymbidium kanran Using Deep Eutectic Solvents.Vicenin-2 inhibits Wnt/β-catenin signaling and induces apoptosis in HT-29 human colon cancer cell line.
P2860
Q28482104-985571B5-DC0B-475E-8FD9-028A472B2058Q33702987-5354CF77-E0F3-422B-A62F-25354B3261D7Q34366965-6DB53F8C-858A-43DB-9534-F535A0928781Q36137473-2EC8F532-1FCD-48D7-91CE-6DE94D837F10Q38107515-94490434-D874-4C4D-AE01-3104870DBB64Q38152399-288B6D01-8FFC-4AC8-85E5-4999E8B5C576Q38835612-E22FF9A3-BDCC-44D2-84A2-75A524223661Q38870620-425CA5F1-8FBF-4A1D-B758-A09519E39B99Q38987203-676C5C6B-1168-4AFF-92D3-07E4B5386DB4Q39209358-92517E85-03BD-4C10-98F6-AED4B53C507BQ39420720-EC9BE13C-F4A9-494B-987E-2E0145C7CF85Q40238740-4AE1C3F3-BEAF-43B4-BDEE-6BDBB43F871BQ40934760-A9E9683C-2345-42B3-BFB2-CA54763DC185Q44297831-9DFC22E7-C9A1-4DB2-B47F-E0A70BBC0D30Q46232992-48805982-3378-4190-A272-9E1B59663721Q46739626-40E33B4A-151B-4057-AA52-A737C52653E5Q47567895-F980DB9E-C647-4130-93DF-944328A89360Q47788818-F85B9F65-5AD0-43FB-9486-A0A8AAFC2091Q54977607-2317EA28-998F-428A-B0BC-F03434B8EB41
P2860
Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Anti-cancer effects of novel f ...... h docetaxel in prostate cancer
@ast
Anti-cancer effects of novel f ...... h docetaxel in prostate cancer
@en
type
label
Anti-cancer effects of novel f ...... h docetaxel in prostate cancer
@ast
Anti-cancer effects of novel f ...... h docetaxel in prostate cancer
@en
prefLabel
Anti-cancer effects of novel f ...... h docetaxel in prostate cancer
@ast
Anti-cancer effects of novel f ...... h docetaxel in prostate cancer
@en
P2093
P2860
P1476
Anti-cancer effects of novel f ...... h docetaxel in prostate cancer
@en
P2093
Jyotsana Singhal
Lokesh Dalasanur Nagaprashantha
Rhonda Roby
Rit Vatsyayan
Sanjay Awasthi
Sharad S Singhal
Spence Fast
P2860
P304
P356
10.1016/J.BCP.2011.07.078
P407
P577
2011-07-23T00:00:00Z